• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CORCYM CANADA CORP. PERCEVAL SUTURELESS AORTIC HEART VALVE; TISSUE HEART VALVES

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CORCYM CANADA CORP. PERCEVAL SUTURELESS AORTIC HEART VALVE; TISSUE HEART VALVES Back to Search Results
Model Number TBD
Device Problem Insufficient Information (3190)
Patient Problem Thrombocytopenia (4431)
Event Type  Injury  
Manufacturer Narrative
The manufacturer is confirming the exact number of devices involved in the event.If applicable a separate medwatch will be submitted should further devices being identified.No evidence of device being explanted.
 
Event Description
The manufacturer was informed of a thrombocytopenia event after the implantation of the perceval valve.According to the information available, the platelet counts dropped to 30k in 2 cases.There is no further information available at this time.
 
Manufacturer Narrative
Fields updated: b4, g3, g6, h2, h3, h6 since no information is available regarding the device disposition and the serial number, further investigation is not possible.Based on the limited information available, it is not possible to establish a definitive root cause of this event.Thrombocytopenia (tcp) in cardiac surgery is a very well-known phenomenon.The etiology is multi-factorial due to multiple factors including hemodilution, blood loss with volume repletion with platelet-poor fluids, platelet activation, consumption and destruction due to contact with foreign surfaces.Tcp following aortic valve replacement (avr) is also a common phenomenon.Patient factors and prolonged extracorporeal circulation all being recognized predictors of tcp following cardiac surgery.The manufacturer attempted to follow up with the field but no further information was received.Should any further information be received in the future, the manufacturer will provide an update to this reporting activity as applicable.H3 other text : no evidence of device being explanted.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PERCEVAL SUTURELESS AORTIC HEART VALVE
Type of Device
TISSUE HEART VALVES
Manufacturer (Section D)
CORCYM CANADA CORP.
5005 north fraser way
burnaby, bc
Manufacturer (Section G)
CORCYM CANADA CORP.
5005 north fraser way
burnaby, bc
Manufacturer Contact
francesca crovato
5005 north fraser way
burnaby, bc 
MDR Report Key13213189
MDR Text Key285353972
Report Number3004478276-2022-00112
Device Sequence Number1
Product Code LWR
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 03/11/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberTBD
Device Catalogue NumberTBD
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 12/13/2021
Initial Date FDA Received01/10/2022
Supplement Dates Manufacturer Received03/11/2022
Supplement Dates FDA Received03/12/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
-
-